Edition:
India

People: Biohaven Pharmaceutical Holding Company Ltd (BHVN.N)

BHVN.N on New York Stock Exchange

46.89USD
20 Sep 2019
Change (% chg)

$-0.81 (-1.70%)
Prev Close
$47.70
Open
$47.52
Day's High
$47.52
Day's Low
$46.17
Volume
877,271
Avg. Vol
205,358
52-wk High
$67.86
52-wk Low
$29.17

Engelhart, James 

Mr. James Engelhart serves as Chief Financial Officer, Treasurer of Biohaven Pharmaceutical Holding Company Limited. Mr. Engelhart has served as our chief financial officer since May 2016. Prior to this, from August 2014 to May 2016, he served as executive director of finance, Americas for Alexion Pharmaceuticals, Inc., and from March 2006 to July 2014, he served as a finance director for Energizer Holdings, Inc. From May 1998 to March 2006, Mr. Engelhart served in increasingly senior finance roles for BMS and held finance roles in R&D Operations and International Operations at Schering-Plough from 1992 to 1998. Mr. Engelhart currently serves on the board of directors of OLM School of Madison. Mr. Engelhart started his career as an auditor with Coopers & Lybrand LLP from 1986 through 1991. Mr. Engelhart received his B.S. in accounting from Villanova University and is a CPA (inactive).

Basic Compensation

Total Annual Compensation, USD 3,203,040
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 14,028
Fiscal Year Total, USD 3,217,070

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 15,000 486,173.00
Name Fiscal Year Total

Declan Doogan

706,360

Vlad Coric

7,854,000

James Engelhart

3,217,070

Kimberly Gentile

2,784,540

Charles Conway

2,792,860

Robert Berman

521,060
As Of  31 Dec 2018